IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine
Authors
Keywords
-
Journal
Mucosal Immunology
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-16
DOI
10.1038/s41385-018-0073-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice withBordetella pertussis
- (2017) Mieszko M. Wilk et al. JOURNAL OF IMMUNOLOGY
- Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination
- (2017) R HM Raeven et al. Mucosal Immunology
- A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses
- (2017) Takumi Moriuchi et al. PLoS One
- Live pertussis vaccines: will they protect against carriage and spread of pertussis?
- (2016) C. Locht CLINICAL MICROBIOLOGY AND INFECTION
- IL-17–Producing Innate and Pathogen-Specific Tissue Resident Memory γδ T Cells Expand in the Lungs ofBordetella pertussis–Infected Mice
- (2016) Alicja Misiak et al. JOURNAL OF IMMUNOLOGY
- Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses
- (2016) D Christensen et al. Mucosal Immunology
- The human intestinal B-cell response
- (2016) J Spencer et al. Mucosal Immunology
- Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells
- (2016) René H. M. Raeven et al. PLoS One
- Asymptomatic transmission and the resurgence of Bordetella pertussis
- (2015) Benjamin M. Althouse et al. BMC Medicine
- Seroprevalence of Pertussis in The Gambia
- (2015) Susana Scott et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Evaluation of the Impact of a Pertussis Cocooning Program on Infant Pertussis Infection
- (2015) C. Mary Healy et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Live attenuated vaccines against pertussis
- (2014) Camille Locht et al. Expert Review of Vaccines
- Pertussis Resurgence: Perspectives From the Working Group Meeting on Pertussis on the Causes, Possible Paths Forward, and Gaps in Our Knowledge
- (2014) D. L. Burns et al. JOURNAL OF INFECTIOUS DISEASES
- A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers
- (2014) Rigmor Thorstensson et al. PLoS One
- Live Attenuated B. pertussis BPZE1 Rescues the Immune Functions of Respiratory Syncytial Virus Infected Human Dendritic Cells by Promoting Th1/Th17 Responses
- (2014) Ilaria Schiavoni et al. PLoS One
- Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: A cross-sectional study
- (2014) Qi Zhang et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
- (2013) Pádraig J. Ross et al. PLoS Pathogens
- Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak
- (2012) Maxwell A. Witt et al. CLINICAL INFECTIOUS DISEASES
- Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates
- (2012) J M Warfel et al. Mucosal Immunology
- Immunity to the respiratory pathogen Bordetella pertussis
- (2012) R Higgs et al. Mucosal Immunology
- Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease
- (2012) James D. Cherry NEW ENGLAND JOURNAL OF MEDICINE
- Attenuated Bordetella pertussis Vaccine Candidate BPZE1 Promotes Human Dendritic Cell CCL21-Induced Migration and Drives a Th1/Th17 Response
- (2011) G. Fedele et al. JOURNAL OF IMMUNOLOGY
- Dose Response of Attenuated Bordetella pertussis BPZE1-Induced Protection in Mice
- (2010) N. Mielcarek et al. Clinical and Vaccine Immunology
- T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis
- (2010) Pascal Feunou Feunou et al. PLoS One
- Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
- (2010) Sabine C. de Greeff et al. PLoS One
- Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1
- (2010) Pascal Feunou Feunou et al. VACCINE
- Cutting Edge: Lung Mucosal Th17-Mediated Responses Induce Polymeric Ig Receptor Expression by the Airway Epithelium and Elevate Secretory IgA Levels
- (2009) Z. Jaffar et al. JOURNAL OF IMMUNOLOGY
- Pathology and Pathogenesis of FatalBordetella pertussisInfection in Infants
- (2008) Christopher D. Paddock et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started